Global Axial Spondyloarthritis Treatment Market 2018-2022

体軸性脊椎関節炎治療の世界市場2018-2022

◆タイトル:Global Axial Spondyloarthritis Treatment Market 2018-2022
◆商品コード:IRTNTR23587
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年10月31日
◆ページ数:108
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥381,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

体軸性脊椎関節炎治療の市場は、主に脊椎および仙腸関節に影響を及ぼす関節リウマチ疾患の治療に使用される薬物を対象としています。体軸性脊椎関節炎治療の世界市場は、2018〜2022年の間、年平均成長率7.37%で成長すると予測されています。

主な分析対象企業は、AbbVie、Amgen、Johnson & Johnson、Pfizer、UCBなどです。

当調査レポートでは、体軸性脊椎関節炎治療の世界市場について調査・分析し、市場概要、市場環境、体軸性脊椎関節炎治療市場規模、カテゴリー別(体軸性脊椎関節炎の治療、非レントゲン性体軸性脊椎関節炎の治療)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。

・エグゼクティブサマリー
・調査範囲・調査手法
・体軸性脊椎関節炎治療の世界市場概要
・体軸性脊椎関節炎治療の世界市場環境
・体軸性脊椎関節炎治療の世界市場動向
・体軸性脊椎関節炎治療の世界市場規模
・体軸性脊椎関節炎治療の世界市場:業界構造分析
・体軸性脊椎関節炎治療の世界市場:カテゴリー別(体軸性脊椎関節炎の治療、非レントゲン性体軸性脊椎関節炎の治療)
・体軸性脊椎関節炎治療の世界市場:地域別市場規模・分析
・体軸性脊椎関節炎治療の北米市場規模・予測
・体軸性脊椎関節炎治療のヨーロッパ・中東・アフリカ市場規模・予測
・体軸性脊椎関節炎治療のアジア太平洋市場規模・予測
・体軸性脊椎関節炎治療の主要国分析
・体軸性脊椎関節炎治療の世界市場:意思決定フレームワーク
・体軸性脊椎関節炎治療の世界市場:成長要因、課題
・体軸性脊椎関節炎治療の世界市場:競争環境
・体軸性脊椎関節炎治療の世界市場:関連企業情報(ベンダー分析)

About Axial Spondyloarthritis Treatment
Axial spondyloarthritis treatment market covers the drugs used for the treatment of inflammatory rheumatic disease, which predominantly affects the spine and sacroiliac joints.
Technavio’s analysts forecast the Global Axial Spondyloarthritis Treatment Market to grow at a CAGR of 7.37% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the axial spondyloarthritis treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of axial spondyloarthritis across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, axial spondyloarthritis treatment market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• AbbVie
• Amgen
• Johnson & Johnson
• Pfizer
• UCB
Market driver
• Increase in the number of approved biosimilars
• For a full, detailed list, view our report

Market challenge
• High cost of biologics
• For a full, detailed list, view our report

Market trend
• Increase in the number of small molecules in the drug development pipeline
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: PIPELINE LANDSCAPE
PART 08: MARKET SEGMENTATION BY CATEGORY
• Segmentation by category
• Comparison by category
• Global ankylosing spondylitis treatment market – Market size and forecast 2017-2022
• Global non-radiographic axial spondyloarthritis treatment market – Market size and forecast 2017-2022
• Market opportunity by category
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie
• Amgen
• Johnson & Johnson
• Pfizer
• UCB
PART 16: APPENDIX
• List of abbreviations



Exhibit 01: Parent market
Exhibit 02: Global axial spondyloarthritis treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global axial spondyloarthritis treatment market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global axial spondyloarthritis treatment market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Pipeline landscape by development phase 2018
Exhibit 19: Key clinical trial candidates of axial spondyloarthritis 2017-2018
Exhibit 20: Global axial spondyloarthritis treatment market by category– Market share 2017-2022 (%)
Exhibit 21: Comparison by category
Exhibit 22: Global ankylosing spondylitis treatment market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global ankylosing spondylitis treatment market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global non-radiographic axial spondyloarthritis treatment market – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global non-radiographic axial spondyloarthritis treatment market – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by category
Exhibit 27: Customer landscape
Exhibit 28: Global axial spondyloarthritis treatment market by geography – Market share 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in the Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: AbbVie: Overview
Exhibit 46: AbbVie – Business segments
Exhibit 47: AbbVie – Organizational developments
Exhibit 48: AbbVie – Geographic focus
Exhibit 49: AbbVie – Key offerings
Exhibit 50: AbbVie – Key customers
Exhibit 51: Amgen: Overview
Exhibit 52: Amgen – Business segments
Exhibit 53: Amgen – Organizational developments
Exhibit 54: Amgen – Geographic focus
Exhibit 55: Amgen – Key offerings
Exhibit 56: Amgen – Key customers
Exhibit 57: Johnson & Johnson: Overview
Exhibit 58: Johnson & Johnson– Business segments
Exhibit 59: Johnson & Johnson– Organizational developments
Exhibit 60: Johnson & Johnson– Geographic focus
Exhibit 61: Johnson & Johnson– Segment focus
Exhibit 62: Johnson & Johnson– Key offerings
Exhibit 63: Johnson & Johnson– Key customers
Exhibit 64: Pfizer: Overview
Exhibit 65: Pfizer – Business segments
Exhibit 66: Pfizer – Organizational developments
Exhibit 67: Pfizer – Geographic focus
Exhibit 68: Pfizer– Segment focus
Exhibit 69: Pfizer – Key offerings
Exhibit 70: Pfizer – Key customers
Exhibit 71: UCB: Overview
Exhibit 72: UCB – Business segments
Exhibit 73: UCB – Organizational developments
Exhibit 74: UCB – Geographic focus
Exhibit 75: UCB – Key offerings
Exhibit 76: UCB – Key customers



【掲載企業】

AbbVie、Amgen、Johnson & Johnson、Pfizer、UCB

★調査レポート[体軸性脊椎関節炎治療の世界市場2018-2022] (Global Axial Spondyloarthritis Treatment Market 2018-2022 / IRTNTR23587 )販売に関する免責事項
[体軸性脊椎関節炎治療の世界市場2018-2022] (Global Axial Spondyloarthritis Treatment Market 2018-2022 / IRTNTR23587 )についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆